top of page

First-mover market authorizer, tele-health clinic, importer & wholesaler in Poland with 15% market share

Leading medical cannabis Telehealth & market authorisation service provider in Poland with established sales and distribution channels offers optimal route to the Polish market, building on 15% current market share!

Listing ID:

17077476691

Licence(s) Held:

Medical Services and Pharma-oriented Activities

Cannabis leaf on the Poland flag for a medical cannabis telehealth investment.

Seeking strategic equity partner to invest $2 million USD

Listing Details:

A market-leading Polish cannabis telehealth clinic with 15% market share is seeking a $2M partner. With strong online presence, secured licenses, and a pending product launch, it offers fast access to Poland’s growing cannabis market. Includes B2B growth potential and a fully built-out local supply chain.

  • Premier medical operator in Poland, focused on patient-centric online services, specializing in the provision of medical clinics and cannabis treatment products

  • Distinctive business model, marked by vertical integration and strong value chain synergies, excels in delivering high-quality medical care that outshines competitors

  • Currently, company serves as the largest clinic in Poland, providing pharmaceutical prescriptions and various supplies to medical patients

  • Listed as a market-authorized medical entity of cannabis products by the Polish Authority

  • Demonstrated success as an SEO pioneer with a data-driven approach and a robust e-commerce infrastructure with 3.4 million website views and over 100 published thematic articles in 2022

  • Presently in the process of registering 7 cannabis flower SKUs and 1 oil extract SKU through their partner in the Polish market

  • Projected launch of branded medical cannabis products by Q3 2024, with an anticipated 15% market share in the dried flower market and a significant market share in the medical cannabis patient market in Poland

  • Boasts a world-class team of executives, operational experts, and medical professionals, bolstered by strong investors, institutional groups, and professional advisors

  • Enhanced market presence via competitor acquisition, securing supply agreements and B-2-B agreements for Poland, and collaborating with patient associations and prestigious medical organizations

  • Actively seeking an equity partner to strategically expand market share in Poland and other European markets

17077476691

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal

NEW CANNABIS BUSINESSES FOR SALE

See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.

Cannabis New/Featured Business Listing - Merger & Acquisition

36324927098

Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Cannabis New/Featured Business Listing - Merger & Acquisition

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

Cannabis New/Featured Business Listing - Merger & Acquisition

38939049737

4,800 sq ft licensed, micro-cultivation facility in AB for $500k

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a turnkey, fully built, turnkey 4,800 sq ft micro-cultivation facility in AB, offered at a significant discount to replacement cost

Cannabis New/Featured Business Listing - Merger & Acquisition

29345918591

State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.

bottom of page